Summiting the Precision Medicine Mountain
Top thinkers gather at UCSF to help make the new field a reality.
University of California San Francisco
Give to UCSF
MEDIA ADVISORY: QB3 and City Celebrate Launch of New Bioscience Incubator
The California Institute for Quantitative Biosciences (QB3) will hold a news conference and media tours to launch the institute’s new bioscience incubator, near the UC San Francisco campus at Mission Bay.
UCSF Joins Genentech, Google as Founding Partners to Foster Green Building as Public Health Benefit
UCSF has joined as a founding partner with Adobe, Genentech, Google, Kaiser Permanente, salesforce.com and 20 other corporations and institutions to elevate green building as a public health benefit.
LaunchPad Focuses on Catalyzing Early Stage Research: Q&A with Ruben Rathnasingham
Ruben Rathnasingham, PhD, associate director of Early Translational Research at UCSF's Clinical and Translational Science Institute, is leading the team responsible for LaunchPad. In this Q&A, he discusses the project and how it can benefit researchers.
Sugar Helps Scientists Find and Assess Prostate Tumors
A natural form of sugar could offer a noninvasive way to precisely image tumors and determine whether cancer medication is effective using new technology developed at UCSF in collaboration with GE Healthcare.
Pfizer’s Centers for Therapeutic Innovation Partners with UCSF to Expand Drug Discovery Capabilities
Pfizer has announced the expansion of its Centers for Therapeutic Innovation into the development of small-molecule drug candidates through a partnership with UCSF.
UCSF Award Program Guides Promising Early-Stage Research Toward Patient Benefit
<p>An innovative project to develop a potential therapy to treat a wide range of cancers has won a major UC San Francisco award that aims to drive promising early-stage research through the complex process of translating ideas into patient benefit.</p>
UCSF to Convene Summit to Drive the Precision Medicine Revolution
<p>UCSF is convening some of the world’s foremost thought leaders for a two-day summit to chart the course of precision medicine, an emerging field aimed at revolutionizing medical care.</p>
Partnering with Public Schools
How UCSF is supporting science teachers and redefining the chance of academic success for disadvantaged students.
UCSF Chancellor Susan Desmond-Hellmann Featured on BioCentury This Week
<p>UCSF Chancellor Susan Desmond-Hellmann, MD, former president for product development at Genentech, is featured in a video interview for BioCentury Publications Inc., a major biopharmaceutical news media source, which first aired online on Dec. 11.</p>
NAS Report Calls for Building Biomedical Knowledge Network to Drive Precision Medicine
<p>A National Academy of Sciences committee co-chaired by UCSF Chancellor Susan Desmond-Hellmann, MD, MPH, recommends the creation of a Google maps-like data network that could transform the future of medical discovery, diagnosis and treatment.</p>